Discovery Cure Institute, Inc. (DCI) is a certified 501(c)(3) Florida Non-Profit Corporation that focuses on the discovery of innovative cures for cancer, infectious diseases, and CNS disorders. With state-of-the-art equipment and a library of 800,000 compounds, DCI conducts high-throughput and in silico screening to identify potential treatments. Through partnerships with Alchem Laboratories Corporation, DCI is able to rapidly identify active compounds and modulate biomolecular pathways, contributing to the advancement of drug discovery.
DCI's capabilities include assay development, ultra high-throughput screening, computational chemistry, and computer-aided drug design. Their uHTS screening facility, equipped with a carousel system and integrated robots, allows for the efficient preparation, incubation, and analysis of multiple plates simultaneously. With a focus on hit to lead and lead optimization stages, DCI aims to develop promising lead compounds for further drug development and clinical trials.
Generated from the website